Pfizer (PFE) reported Q1 FY 2020 earnings of $0.80 per share (versus $0.85 per share in Q1 FY 2019), beating analysts' consensus estimate of $0.71 per share.
The company's quarterly revenues amounted to $12.028 bln (-8.3% y/y), beating analysts' consensus estimate of $11.381 bln.
The company also reaffirmed guidance for FY 2020, projecting EPS of $2.82-2.92 versus analysts' consensus estimate of $2.70 and revenues of $48.5-50.5 bln versus analysts' consensus estimate of $47.01 bln.
PFE rose to $39.00 (+1.75%) in pre-market trading.